Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9753 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9509 |
High Similarity |
NPD6797 |
Phase 2 |
0.9451 |
High Similarity |
NPD7251 |
Discontinued |
0.9277 |
High Similarity |
NPD7808 |
Phase 3 |
0.9268 |
High Similarity |
NPD7054 |
Approved |
0.9212 |
High Similarity |
NPD7472 |
Approved |
0.9207 |
High Similarity |
NPD3818 |
Discontinued |
0.9096 |
High Similarity |
NPD7074 |
Phase 3 |
0.9068 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8944 |
High Similarity |
NPD3817 |
Phase 2 |
0.8922 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8855 |
High Similarity |
NPD6166 |
Phase 2 |
0.8855 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8855 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8712 |
High Similarity |
NPD5402 |
Approved |
0.8706 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8704 |
High Similarity |
NPD1934 |
Approved |
0.8679 |
High Similarity |
NPD1512 |
Approved |
0.8659 |
High Similarity |
NPD3882 |
Suspended |
0.865 |
High Similarity |
NPD2801 |
Approved |
0.865 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8606 |
High Similarity |
NPD7075 |
Discontinued |
0.8553 |
High Similarity |
NPD1511 |
Approved |
0.8509 |
High Similarity |
NPD5403 |
Approved |
0.8476 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8466 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8424 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8333 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8232 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8222 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.816 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8103 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8081 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.8063 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8023 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8012 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7988 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7977 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7975 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7965 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7955 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7943 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7933 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7931 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7845 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7824 |
Intermediate Similarity |
NPD37 |
Approved |
0.7816 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD919 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7791 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7789 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD2796 |
Approved |
0.775 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.773 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7717 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7688 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7684 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7632 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7614 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7578 |
Intermediate Similarity |
NPD943 |
Approved |
0.7572 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7551 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7528 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7527 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7453 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7424 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7424 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7423 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7423 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7423 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7394 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7385 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7385 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6534 |
Approved |
0.736 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD920 |
Approved |
0.7326 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7254 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7239 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7135 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7118 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7088 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7045 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7041 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7022 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7021 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.701 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7006 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.6975 |
Remote Similarity |
NPD3225 |
Approved |
0.6966 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD6651 |
Approved |
0.6959 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD5242 |
Approved |
0.6954 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6951 |
Remote Similarity |
NPD9494 |
Approved |
0.6947 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6935 |
Remote Similarity |
NPD5005 |
Approved |
0.6935 |
Remote Similarity |
NPD5006 |
Approved |
0.6928 |
Remote Similarity |
NPD3268 |
Approved |
0.6919 |
Remote Similarity |
NPD2403 |
Approved |
0.6918 |
Remote Similarity |
NPD9268 |
Approved |
0.6914 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6905 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6901 |
Remote Similarity |
NPD2344 |
Approved |
0.6894 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6893
|
Remote Similarity |
NPD7930 |
Approved |